Genetc and morphologic features for melanoma classification: implications for clinical trials

Sigrid M. C. Broekaert; Rupak Roy; Ichiro Okamoto; Joost van den Oord; Jürgen Bauer; Claus Garbe; Barnhill Rl; K. Busam; Cochran Aj; MG Cook; Elder De; SW McCarthy; M. Mihm; Dirk Schadendorf; Richard A Scolyer; Alan Spatz; BC Bastian

Article2010

Genetic and morphologic features for melanoma classification

Sigrid M. C. Broekaert, Ritu Roy, Ichiro Okamoto, Joost van den Oord, Jürgen Bauer, Claus Garbe, Raymond L. Barnhill, Klaus J. Busam, Alistair J. Cochran, Martin Cook, David E. Elder, Stanley W. McCarthy, Martín C. Mihm, Dirk Schadendorf, Richard A Scolyer, Alan Spatz, Boris C. Bastian

Article2019

Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

Jarem Edwards, Annie Tasker, Inês Pires da Silva, Camelia Quek, Marcel Batten, Angela L. Ferguson, Ruth Allen, Benjamin Allanson, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Umaimainthan Palendira, James S. Wilmott, Georgina V. Long, Richard A Scolyer

Article2011

Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma

Rajmohan Murali, Diana Zannino, Maria Synnott, Stanley W. McCarthy, John F. Thompson, Richard A Scolyer

Preprint2023

Data from Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

Jarem Edwards, Annie Tasker, Inês Pires da Silva, Camelia Quek, Marcel Batten, Angela L. Ferguson, Ruth Allen, Benjamin Allanson, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Umaimainthan Palendira, James S. Wilmott, Georgina V. Long, Richard A Scolyer

Preprint2023

Data from Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

Jarem Edwards, Annie Tasker, Inês Pires da Silva, Camelia Quek, Marcel Batten, Angela L. Ferguson, Ruth Allen, Benjamin Allanson, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Umaimainthan Palendira, James S. Wilmott, Georgina V. Long, Richard A Scolyer

Genetc and morphologic features for melanoma classification: implications for clinical trials

Discussion(0)

Related publications

Genetic and morphologic features for melanoma classification

Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma

Data from Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

Data from Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials